Surgery Partners, Inc. filed a Form 8-K on November 18, 2026, disclosing that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc., amended its ongoing consent solicitation for holders of $1,225,000,000 in 7.250% Senior Notes due 2032, increasing the consent fee from $2.50 to $5.00 per $1,000 in principal amount of Notes.
Key Highlights
- Consent fee doubled: The fee payable to qualifying noteholders was increased from $2.50 to $5.00 per $1,000 in principal amount of Notes.
- Notes outstanding: The solicitation covers $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032.
- Expiration deadline: The Consent Solicitation is set to expire at 5:00 p.m., New York City time, on November 20, 2026, unless extended or earlier terminated.
- Merger context: The solicitation relates to a previously announced Agreement and Plan of Merger, dated October 23, 2026, with Spyglass Topco, LLC, as amended by Amendment No. 1 dated November 8, 2026.
- Change of Control provision: Without the Proposed Amendments, consummation of the Merger would constitute a "Change of Control" under the Indenture, according to the filing.
- Permitted Holders amendment: The proposed amendments would designate BSMH, HealthSpan Partners, and their respective affiliates as "Permitted Holders" under the Indenture.
Surgery Partners Amends Indenture Consent Solicitation Ahead of Planned Merger
According to the filing, Surgery Center Holdings, Inc., an indirect wholly owned subsidiary of Surgery Partners, Inc. (NASDAQ:SGRY), amended its consent solicitation on November 18, 2026, raising the consent fee for holders of its 7.250% Senior Notes due 2032. The fee increase, from $2.50 to $5.00 per $1,000 in principal amount, applies to holders who validly deliver and do not revoke their consents before the solicitation expires at 5:00 p.m., New York City time, on November 20, 2026, unless the deadline is extended or the solicitation is earlier terminated.
The company disclosed that the consent solicitation is being conducted in connection with its previously announced merger agreement with Spyglass Topco, LLC, under which Spyglass Merger Subsidiary, Inc. would merge with and into Surgery Partners, leaving the company as a wholly owned subsidiary of Spyglass Topco, LLC. Bon Secours Mercy Health, Inc. ("BSMH") is identified as a party to the Merger Agreement for limited purposes. The filing states that if the Proposed Amendments are not consented to and operative, the Merger's consummation would constitute a "Change of Control" under the Indenture governing the Notes, which was originally dated April 10, 2024, with Wilmington Trust, National Association serving as trustee.
The Proposed Amendments, as described in the filing, would add BSMH, HealthSpan Partners (a 501(c)(3) Ohio corporation affiliated with BSMH), and their respective affiliates as "Permitted Holders" under the Indenture, and would amend certain related defined terms. The filing noted that the Consent Solicitation Statement has been amended twice, with Amendment No. 1 and Amendment No. 2 both dated November 16, 2026 and November 18, 2026, respectively. The filing also clarified that the Proposed Amendments becoming operative is not a condition to the consummation of the Merger.
What Was Disclosed
Surgery Partners disclosed an amendment to a noteholder consent solicitation tied to a pending merger, raising the consent fee to $5.00 per $1,000 principal on $1,225,000,000 of 7.250% Senior Notes due 2032, with the solicitation set to expire November 20, 2026.



Please wait processing your request...